Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.245 EUR | +2.98% | +6.40% | -14.31% |
Sales 2024 * | 46.78M 50.02M 4.01B | Sales 2025 * | 74.41M 79.56M 6.37B | Capitalization | 181M 194M 15.54B |
---|---|---|---|---|---|
Net income 2024 * | -25M -26.73M -2.14B | Net income 2025 * | -21M -22.45M -1.8B | EV / Sales 2024 * | 2.48 x |
Net cash position 2024 * | 65.68M 70.23M 5.62B | Net cash position 2025 * | 122M 130M 10.41B | EV / Sales 2025 * | 0.8 x |
P/E ratio 2024 * |
-15.5
x | P/E ratio 2025 * |
3.71
x | Employees | 179 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.91% |
Latest transcript on Innate Pharma
1 day | +2.98% | ||
1 week | +6.40% | ||
Current month | +2.75% | ||
1 month | +2.28% | ||
3 months | -10.74% | ||
6 months | -4.06% | ||
Current year | -14.31% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Vivier
FOU | Founder | 60 | 22/09/99 |
Chief Executive Officer | 62 | 22/09/99 | |
Frederic Lombard
DFI | Director of Finance/CFO | 49 | 31/03/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 22/09/99 | |
Gilles Brisson
BRD | Director/Board Member | 72 | 25/06/07 |
Olivier Martinez
BRD | Director/Board Member | 54 | 24/05/10 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 2.245 | +2.98% | 61,472 |
25/04/24 | 2.18 | -2.46% | 19,133 |
24/04/24 | 2.235 | -1.11% | 60,896 |
23/04/24 | 2.26 | +4.39% | 79,753 |
22/04/24 | 2.165 | +2.61% | 34,564 |
Real-time Euronext Paris, April 26, 2024 at 04:35 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.31% | 194M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- IPH Stock